Table 3.

Summary of product caracteristics (SmPC) for 6-thioguanine

Genric name (abbreviation)		6-thioguanine (6TG)
ATC-code		ATC-code L0JBB03
Name and formulation		Oral suspension, 5 mg/ml
Adverse Reactions (frequency)	Very common (> 1/10)	Bone marrow failure, sinusoidal obstruction syndrome (SOS), hyperbilirubinemia, hepatomegaly, weight increase due to fluid retention and ascites, portal hypertension, splenomegaly, esophageal varices and thrombocytopenia, increased hepatic enzymes, increased blood alkaline phosphatase and gamma glutamyl transferase, jaundice, portal fibrosis, nodular regenerative hyperplasia, peliosis hepatis
	Common (> 1/100 to < 1/10)	Stomatitis, gastrointestinal disorder, SOS in short-term cyclical therapy, hyperuricemia, hyperuricosuria and urate nephopathy
	Uncommon (≥1/1000 to < 1/100)
	Rare (≥1/10,000 to < 1/1000)	Necrotising colitis, hepatic necrosis
	Very rare (< 1/10,000)
	Unknown	Photosensitivity

SmPC accessed at medicines.org.uk